NEW: Physician briefing papers from APC
One-pagers help you help prescribers understand compounding.
One-pagers help you help prescribers understand compounding.
Last week, we asked for your help in encouraging physicians to sign our letter to FDA expressing concern about its implicit threat to restrict cBHT—and you heard the call and answered.
APC has confirmed that two members of Congress who serve on key committees with oversight over pharmacy compounding in the U.S. Senate and House will speak at Compounders on Capitol Hill.
A joint APC-NCPA letter submitted last week to FDA Center for Veterinary Medicine’s Dr. Bill Flynn includes more than 2 dozen questions on which the associations seek great clarity regarding the agency’s animal compounding GFI.
Need an additional incentive to attend this year's CCH? Register today and take advantage of our early-bird pricing $495 through July 31 (on August 1 it goes up to $549).
We’re hearing from members of Congress that they’ve heard a lot from pharmacists on this issue, but not much at all from physicians.
There's still time to be part of our group purchasing opportunity to reduce credit card processing fees.
If compounding hormones is a part of your compounding business, we know you’re concerned about FDA’s implicit threat to introduce restrictions. It's time for you to ask your prescribing physicians to show their support.